Vaginal Microbiocenosis Features in HIV-positive Women of Fertile Age
Anait Yuryevna Marianian *
Federal State Public Scientific Institution, Scientific Centre for Family Health and Human Reproduction Problems, Irkutsk, Russia.
Maria Alexandrovna Rashidova
Federal State Public Scientific Institution, Scientific Centre for Family Health and Human Reproduction Problems, Irkutsk, Russia.
Lyubov Ilinichna Kolesnikova
Federal State Public Scientific Institution, Scientific Centre for Family Health and Human Reproduction Problems, Irkutsk, Russia.
*Author to whom correspondence should be addressed.
Abstract
Aim and Objective of Our Study: The aim and objective of our study is to analyze the research data that has been studying the effect of HIV infection on vaginal microbiocenosis and further, to determine the differences in dysbiotic disorders in seronegative and seropositive women. We have also assessed the effect of vaginal microbiota on pre-exposure prophylaxis of HIV.
Materials and Methods: Evaluation of the Russian and other countries results on the microbiota of HIV-positive women studies, published in international databases.
Results: The analysis of the research data aimed at studying the effect of HIV infection on the vaginal microbiocenosis indicates that dysbiotic disorders in HIV-infected patients are significantly more frequent. It has been revealed that the atypical clinical picture of changes in the vaginal microbiocenosis prevails. It has been noted that there is a correlation of vaginal microbiocenosis in HIV-positive women and indicators of systemic immunity, CD4 + cell levels.
Conclusion: Based on analysis of published in international databases Russian and other countries studies results on the HIV-positive women microbiota, it was found that there is a need for additional studies of the qualitative and quantitative composition of the microbiota of HIV-positive women. It is need to assess the of the vaginalmicrobiotaand other possible connected factors ability to change the concentration of antiretroviral drugs.
Keywords: Vaginalmicrobiocenosis, HIV infection, dysbiotic disorders.